Medical Research > Toxoplasma gondii

Tracking since May 19, 2026 · Latest signal Apr 20, 2026 · 10 matched data points

Overall sentiment

Positive 0% (0)Negative 0% (0)Neutral 100% (10)

Daily sentiment

Claims (1)

Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.

The mitochondrial bc1-complex in mature Toxoplasma gondii bradyzoites is a viable drug target for eliminating persistent tissue cysts.

Parent: Medical ResearchEntity: Toxoplasma gondiiSub-entity: bradyzoitesImpact: positiveDate: Apr 20, 2026Target: The mitochondrial bc1-complex as a drug target for treating Toxoplasma gondii infections.10 matched entries0 confirmed0 disputed10 neutral0 unclear